Abstract |
To determine the relevance of MGMT in Barrett's carcinogenesis, we analyzed promotor hypermethylation and expression of MGMT in Barrett's adenocarcinomas and its paired precursor lesions from 133 patients using a methylation-specific PCR, real-time RT-PCR and immunohistochemistry. Hypermethylation was detected in 78.9% of esophageal adenocarcinomas, in 100% of Barrett's intraepithelial neoplasia, in 88.9% of Barrett's metaplasia, but only in 21.4% of normal esophageal mucosa samples (P<0.001) and correlated significantly with downregulation of MGMT transcripts (P=0.048) and protein expression (P=0.02). Decrease of protein expression was significantly correlated with progressed stage of disease, lymph node invasion and tumor size. We conclude, that aberrant promoter methylation of MGMT is a frequent and early event during tumorigenesis of Barrett's esophagus. High prevalence of MGMT hypermethylation may represent a candidate marker for improved diagnosis and targeted therapy in Barrett's adenocarcinoma.
|
Authors | Doerthe Kuester, Wa'el El-Rifai, DunFa Peng, Petra Ruemmele, Ivonne Kroeckel, Brigitte Peters, Christopher A Moskaluk, Manfred Stolte, Klaus Mönkemüller, Frank Meyer, Hans-Ulrich Schulz, Arndt Hartmann, Albert Roessner, Regine Schneider-Stock |
Journal | Cancer letters
(Cancer Lett)
Vol. 275
Issue 1
Pg. 117-26
(Mar 08 2009)
ISSN: 1872-7980 [Electronic] Ireland |
PMID | 19027227
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Tumor Suppressor Proteins
- DNA Modification Methylases
- MGMT protein, human
- DNA Repair Enzymes
|
Topics |
- Adenocarcinoma
(genetics, metabolism)
- Adult
- Aged
- Barrett Esophagus
(genetics, metabolism)
- Carcinoma
(genetics, metabolism)
- DNA Methylation
- DNA Modification Methylases
(genetics)
- DNA Repair Enzymes
(genetics)
- Disease Progression
- Female
- Gene Silencing
- Humans
- Lymphatic Metastasis
- Male
- Metaplasia
(genetics, metabolism)
- Middle Aged
- Neoplasm Invasiveness
- Tumor Suppressor Proteins
(genetics)
|